SCHEMBL7729456

SCHEMBL7729456

Cc1ccc(S(=O)(=O)O[C@H]2C[C@@H](C(=O)Nc3cnc4ccccc4c3)N(C(=O)OC(C)(C)C)C2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 1/20 0.48
NPC1 O15118 2/20 0.43
POLB P06746 2/20 0.43
RAB9A P51151 2/20 0.43
MAPT P10636 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
MCL1 Q07820 8/20 0.43
KDM4E B2RXH2 2/20 0.43
MITF O75030 1/20 0.43
XBP1 P17861 1/20 0.43
PAX8 Q06710 1/20 0.43
KLF5 Q13887 1/20 0.43
ALDH1A1 P00352 1/20 0.43
ALPL P05186 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2C19 P33261 1/20 0.43
CNR2 P34972 4/20 0.42
CNR1 P21554 3/20 0.42
HDAC8 Q9BY41 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7726525 0.81 POLB (0.56) EPHX2NPC1POLBRAB9AMAPT
SCHEMBL7728992 0.81 POLB (0.56) EPHX2NPC1POLBRAB9AMAPT
SCHEMBL7728996 0.81 POLB (0.56) EPHX2NPC1POLBRAB9AMAPT
SCHEMBL7722250 0.81 POLB (0.46) EPHX2NPC1POLBRAB9AMAPT
SCHEMBL7722254 0.81 POLB (0.46) EPHX2NPC1POLBRAB9AMAPT
SCHEMBL7734120 0.80 NPC1 (0.52) NPC1POLBRAB9AMAPTSMN1; SMN2
SCHEMBL7734121 0.80 NPC1 (0.52) NPC1POLBRAB9AMAPTSMN1; SMN2
SCHEMBL7303267 0.79 MCL1 (0.47) POLBMCL1CYP1A2CYP3A4CYP2C19
SCHEMBL25097911 0.77 NR1H2 (0.47) POLBMCL1ALDH1A1CYP1A2CYP3A4
SCHEMBL6847935 0.77 NR1H2 (0.47) POLBMCL1ALDH1A1CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6399629-B1 PYRROLIDINES AND PIPERIDINES FOR TREATING MICROBIAL INFECTIONS BY REDUCING EXPORT OF COADMINISTERED ANTIMICROBIAL AGENT OR COMPOUND SYNTHESIZED BY MICROBES FOR THEIR GROWTH; REDUCING IN VIVO AVAILABILITY MICROCIDE PHARMACEUTICALS, INC. 2002-06-04 US disclosed